News
NVIDIA delivered strong financial performance in Q1 2026 and maintained momentum in the AI sector, breaking record levels and ...
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback